This signposted external event is not commissioned, organized or facilitated by C&P Training Hub. The availability of these offers are not checked on a daily basis and bookings are done directly with the supplier. You will not be able to see these on your Training Hub Account. Please contact the supplier directly if you have any questions, their contact details should be on your confirmation e-mails.

Morph study days are sponsored by pharmaceutical companies, who provide funding that allows them to offer all events completely free of charge. Sponsors have no involvement in agenda development, speaker selection, or clinical content – this is managed entirely by MORPh’s clinical team.

The “Reducing cardiovascular risks in the diabetic patient: moving beyond HbA1c: PART 1 – Lipids” Webinar is free to access both live and on-demand for attendees. To watch on-demand without attending the webinar you can join the Associate Programmme.

This event will start at 18:30pm with the Welcome and Introductions. The webinar will begin shortly after. Our expert speakers will be discussing the following topics:

Optimising lipids to reduce ASCVD

  • Assessing cardiovascular risk effectively: Using QRISK3 and QRISK Lifetime to guide treatment decisions
  • Understanding lipid-lowering therapies: Benefits and risks of statins and non-statin options in ASCVD prevention
  • Escalating therapy appropriately: When and how to intensify lipid-lowering treatment in line with guidance
  • Managing statin hesitancy and intolerance: Supporting shared decision-making and practical strategies to improve adherence
  • Embedding lipid optimisation into routine reviews: Applying evidence-based, cost-effective prescribing in primary care practice.
  • Structured Medication Review: Case Studies on lipids management